Schiedlauske, K.; Deipenbrock, A.; Pflieger, M.; Hamacher, A.; Hänsel, J.; Kassack, M.U.; Kurz, T.; Teusch, N.E.
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC). Pharmaceuticals 2024, 17, 752.
https://doi.org/10.3390/ph17060752
AMA Style
Schiedlauske K, Deipenbrock A, Pflieger M, Hamacher A, Hänsel J, Kassack MU, Kurz T, Teusch NE.
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC). Pharmaceuticals. 2024; 17(6):752.
https://doi.org/10.3390/ph17060752
Chicago/Turabian Style
Schiedlauske, Katja, Alina Deipenbrock, Marc Pflieger, Alexandra Hamacher, Jan Hänsel, Matthias U. Kassack, Thomas Kurz, and Nicole E. Teusch.
2024. "Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)" Pharmaceuticals 17, no. 6: 752.
https://doi.org/10.3390/ph17060752
APA Style
Schiedlauske, K., Deipenbrock, A., Pflieger, M., Hamacher, A., Hänsel, J., Kassack, M. U., Kurz, T., & Teusch, N. E.
(2024). Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC). Pharmaceuticals, 17(6), 752.
https://doi.org/10.3390/ph17060752